Home/Filings/4/0001209191-21-043202
4//SEC Filing

Bhagat Sarah M 4

Accession 0001209191-21-043202

CIK 0001693011other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 7:48 AM ET

Size

5.5 KB

Accession

0001209191-21-043202

Insider Transaction Report

Form 4
Period: 2021-06-23
Transactions
  • Award

    Stock Option (right to buy)

    2021-06-23+9,3679,367 total
    Exercise: $17.12Exp: 2031-06-22Common Stock (9,367 underlying)
Footnotes (1)
  • [F1]The option was granted on June 23, 2021. The shares underlying the option are scheduled to vest as to 100% of the shares on June 23, 2022, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date.

Issuer

Inozyme Pharma, Inc.

CIK 0001693011

Entity typeother

Related Parties

1
  • filerCIK 0001817762

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 7:48 AM ET
Size
5.5 KB